Restoration of this enzyme function may be a therapeutic approach in ALS and possibly in other disorders where similar TDP-43 pathology has been described, such as frontotemporal dementia, limbic-predominant age-related TDP-43 encephalopathy (LATE) and some cases of Alzheimer’s disease. This evidence concerns the gene TARDBP and early-onset autosomal dominant Alzheimer disease.